Blocking two proteins reverses lung scarring in preclinical study
April 30, 2026
April 30, 2026
ROANOKE, Virginia, April 30 -- The Fralin Biomedical Research Institute at Virginia Tech posted the following news:
* * *
Blocking two proteins reverses lung scarring in preclinical study
*
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in preclinical models.
A new study in the journal Thera . . .
* * *
Blocking two proteins reverses lung scarring in preclinical study
*
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in preclinical models.
A new study in the journal Thera . . .